Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Current Technical Standards Not A Good Fit For Real-World Data, Stakeholders Say
May 10 2022
•
By
Sue Sutter
FDA is trying to shoehord real-world data into existing, but unsuitable, technical standards, industry comments say. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Real-World Evidence
More from Clinical Trials